EBOS Group Limited (NZE: EBO)

Market Cap	7.63B
Revenue (ttm)	14.45B
Net Income (ttm)	297.49M
Shares Out	194.69M
EPS (ttm)	1.55
PE Ratio	25.32
Forward PE	25.81
Dividend	1.25 (3.28%)
Ex-Dividend Date	Aug 29, 2024

Volume	148,663
Average Volume	62,716
Open	38.20
Previous Close	38.20
Day's Range	38.01 - 39.20
52-Week Range	31.02 - 39.20
Beta	0.25
RSI	63.76
Earnings Date	Jan 19, 2025

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 4,963
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: EBO

Financial Performance

In 2024, EBOS Group's revenue was 13.19 billion, an increase of 7.78% compared to the previous year's 12.24 billion. Earnings were 271.55 million, an increase of 7.17%.

Financial numbers in AUD